The bacterium Staphylococcus aureus is a major human pathogen, where the emergence of 2 antibiotic resistance is a global public--health concern. Host factors such as age and the 3 presence of co--morbidities have been implicated in a worse outcome for patient. However, 4 this is complicated by the highly complex and multi--faceted nature of bacterial virulence, 5 which has so far prevented a robust mapping between genotype, phenotype and infection 6 outcome. To investigate the role of bacterial and host factors in contributing to S. aureus 7 bacteraemia--associated mortality we sequenced a collection of clinical isolates (of the MLST 8 clonal complex CC22) from patients with bloodstream infections and quantified specific 9 virulence phenotypes. A genome--wide association scan identified several novel virulence--10 affecting loci, which we validated using a functional genomics approach. Analysing the data 11 comprising bacterial genotype and phenotype as well as clinical meta--data within a 12 machine--learning framework revealed that mortality associated with CC22 bacteraemia is 13 not only influenced by the interactions between host and bacterial factors but can also be 14 predicted at the individual patient--level to a high degree of accuracy. This study clearly 15 demonstrates the potential of using a combined genomics and data analytic approach to 16 enhance our understanding of bacterial pathogenesis. Considering both host and microbial 17 factors, including whole genome sequence and phenotype data, within a predictive 18 framework could thus pave the way towards personalised medicine and infectious disease 19 management. 20 21 22
Introduction 1
Staphylococcus aureus bacteraemia (SAB) is a significant global health problem 1 and is 2 exacerbated by the emergence and widespread circulation of drug resistant strains, such as 3 methicillin--resistant S. aureus, or MRSA 2 . Mandatory surveillance of SAB has now been 4 implemented in several countries, with many reporting a decline in the incidence of 5 methicillin--resistant SAB (MR--SAB) 3--5 . However, in the UK the incidence of methicillin--6 susceptible SAB (MS--SAB) has been increasing year on year, where there has been a 15.4% 7 increase in cases since reporting became mandatory in 2011/2012 3 . Furthermore, the 30 8 day (all--cause) mortality rate for SAB has not significantly changed over the last two decades 9 and appears to have plateaued at approximately 20% 6 . This strongly suggests that existing 10 infection control and treatment options are insufficient to tackle this important health 11 problem and that a better understanding of the factors that contribute to bacteraemia--12 associated morbidity is crucially needed. 13 14
To date, many host risk factors have been identified for both the occurrence of and 15 treatment failure following SAB 6 . However, the contribution of the bacterium is only 16 partially understood and is largely informed by experimental animal studies. These model 17 systems come with their own set of limitations, and many observations from these contrast 18
with those from human studies. For example, whereas cytolytic toxins have previously been 19
shown to enhance disease severity in animal models of SAB 7, 8 , isolates from invasive 20 diseases in humans, such as bacteremia and pneumonia, were recently found to be 21 significantly less toxic than those isolated from skin and soft tissue infections or even those 22 of healthy volunteers 9--12 . This raises the question as to whether animal models are adequate 23 to study bacterial virulence in human SAB infections, or whether there is an important 1 distinction between the role of toxicity in causing bacteremia and its pathogenic effect once 2 bacteremia has been established. Either way, human--based approaches are essential to 3 close this gap in our knowledge. 4 5
Another limitation to our understanding of the pathogenesis of SAB is that most studies 6 focus on only on a single or small number of factors in isolation, host or bacterial. For 7 example, several studies have found increased mortality rates associated with MR--SAB 8 compared to MS--SAB 13, 14 . However, patients with co--morbidities are more likely to develop 9 an MR--SAB due to their impaired health and longer time spent in healthcare facilities when 10 compared to those without comorbidities. When subsequent studies considered both 11 factors together, no difference in mortality was associated with the methicillin resistance 12 status of the infecting bacterium 15 . This illustrates the importance of a more inclusive 13 approach that considers all of the potential host and bacterial factors and examines how 14 their interactions influence the outcome for the patients.
16
We have previously demonstrated how genotype--phenotype mapping in S. aureus has the 17 potential to provide sufficient information to enable predictions of the level of virulence 18 expressed by the infecting microorganism 16 . Here, by expanding this whole--genome 19 approach to a set of fully sequenced isolates from bacteraemic patients and analysing the 20 combined set of genotype, phenotype and clinical meta--data within a machine learning 21 predictive modelling framework we show how host and bacterial factors interact to 22 determine severe infection outcome of S. aureus bacteraemia. These findings pave the way 1 towards individual patient--level predictions and personalised treatment strategies.
3
Material and Methods.
4
Strain and clinical metadata collection. All isolates were collected from adults admitted to a 5 single hospital with their first episode of SAB between 2006 and 2012, and were stored in 6 glycerol at --80°C. Samples were collected during an observational cohort study of adults 7
with SAB at Addenbrooke's Hospital, Cambridge, UK between 2006 and 2012. Written 8 informed consent was not required as the study was conducted as part of a service 9 evaluation of the management of SAB. Ethical approval was obtained from the University of 10 Cambridge Human Biology Research Ethics Committee (reference HBREC.2013.05) and the 11
Cambridge University Hospitals NHS Foundation Trust Research and Development 12
Department (reference A092869). Study definitions have been defined previously 17 and 13 were used to determine the focus of the bacteremia, classify the bacteremia as community--14 acquired, hospital--acquired or healthcare--associated, and to report outcomes, including 15 death at 30 days. The presence of comorbidities was assessed using the Charlson 16 comorbidity index (CCI) and were dichotomized into scores of <3 or ≥3 18, 19 , as detailed in 17 Supplementary Table 1 . 18
Genome Sequencing 19
Bacterial DNA extraction was carried out on a QIAxtractor (Qiagen), and library preparation 20 was performed as previously described 20 . Index--tagged libraries were created, and 96 21 separated libraries were sequenced in each of eight channels using the Illumina HiSeq 22 platform (Illumina) to generate 100--bp paired--end reads at the Wellcome Trust Sanger 23 Institute, UK. Paired--end reads for these isolates were mapped to the ST22/EMRSA15 1 reference strain, HO 5096 0412 21 and SNPs were identified as described previously 21 . The 2 accession number for the sequence data for each of these isolates is listed in Supplementary 3 Table 1 . 4
Cytotoxicity Assay 5
Overnight S. aureus cultures were diluted 1:1000 into fresh tryptone soya broth and 6 incubated for 18 h at 37°C with shaking at 180 rpm in 30 mL glass tubes. S. aureus 7 supernatants were harvested from 18 h cultures by centrifugation at 14,600 rpm for 10 min. 8
The THP--1 human monocyte--macrophage cell line (ATCC#TIB--202) was routinely grown in 9 suspension in 30 mL of of RPMI--1640, supplemented with 10% heat--inactivated fetal bovine 10 serum (FBS), 1 μM L--glutamine, 200 units/mL penicillin, and 0.1 mg/mL streptomycin at 11 37°C in a humidified incubator with 5% CO 2 . Cells were routinely viewed microscopically 12 every 48-60 h and harvested by centrifugation at 1,000 rpm for 10 min at room 13 temperature and re--suspended to a final density of 1-1.2 x 10 6 cells/mL in tissue--grade 14 phosphate buffered saline. This procedure typically yielded >95% viability of cells as 15 determined by trypan blue exclusion and easyCyte flow cytometry. To evaluate S. aureus 16 toxicity, we diluted the supernatant to 30% of the original volume in TSB and incubated 20 17 µL of washed THP--1 cells with 20 µL diluted bacterial supernatant for 12 min at 37°C under 18 static conditions. Cell death was quantified by easyCyte (Millipore) flow cytometry using the 19 Guava Viability stain (Millipore) according to manufacturer's instructions, with the toxicity 20 of each isolate quantified in triplicate and the mean of this presented (listed in 21 Supplementary Table 1) . 22
Biofilm assay 23
Biofilm formation was quantified using a 1:40 dilution from overnight cultures into 100 µL of 1 fresh tryptic soy broth supplemented with 0.5% sterile filtered glucose (TSBG) in 96--well 2 polystyrene plate (Costar). Perimeter wells of the 96--well plate were filled with sterile H 2 O 3 and plates were placed in a separate plastic container inside a 37°C incubator and grown for 4 24 h under static conditions. For the transposon mutants, erythromycin (5 µg/mL) was 5 added to the growth medium. Semi--quantitative measurements of biofilm formation on 96--6 well polystyrene plates was determined based on the method of Ziebuhr et al 22 . Following 7 24--h growth, plates were washed vigorously five times in PBS, dried and stained with 150 μL 8 of 1% crystal violet for 30 min at room temperature. Following five washes of PBS, wells 9
were re--suspended in 200 μL of 7% acetic acid, and optical density at 595 nm was recorded 10 using a Fluorimeter plate reader (BMG Labtech). To control for day to day variability, for the 11 clinical isolates a control strain (E--MRSA15) was included on each plate in triplicate, and 12 absorbance values were normalised against this (listed in Additional Table 1 ). For the 13 transposon mutants, as JE2 is the wild type strain this was used as the control strain, and 14 the effect of mutating the loci made relative to this. For this experiment the assays were 15 performed in triplicate on each plate and repeated four times. 16
Genome wide association study (GWAS) 17
The genome of the reference strain HO 5096 0412 was split into 2095 variable loci, 18 corresponding to coding region and intergenic regions, containing SNPs relative to the 19 reference genome. Annotated intergenic elements such as miscellaneous RNAs were 20 considered separate loci. Synonymous SNPs in coding regions and SNPs in known mobile 21 genetic elements and repeat regions were not considered. The resulting loci were named 22 allele_X where X refers to the position of the SNP at the 5' end of that block, relative to the 23 origin of replication. Each of these alleles in each isolate was scored as 1 if it differed from 1 the reference and 0 if it didn't. These allele scores for each isolate were used as the 2 genotypic information for the following analysis. Significant associations between bacterial 3 genotype and either phenotype (toxicity and biofilm formation) were identified by fitting an 4 analysis of variance model (ANOVA) in R 23 and using a minor allele frequency cut--off of 5%. 5
The reported P values are not corrected for multiple testing; the Bonferroni statistical 6 significance threshold is instead provided in fig. 2 . 7
Predictive modelling. 8
We employed a Random Forests 24 machine learning approach, using the randomForest 9 package in R 25 , to identify predictive signatures of host mortality based on the genotype, 10 phenotype and clinical meta--data. To assess the models' predictive accuracies we employed 11 two different measures: (i) the receiver operating characteristic (ROC) curve, which is 12 generated by plotting the true positive rate against the false positive rate (i.e. the observed 13 incidence against the false predicted incidence) at various threshold settings and where the 14 area under the curve (AUC) is a measure of predictive accuracy, with an AUC=1 equating to 15 zero error and an AUC=0.5 equating to random guessing; and (ii) by means of a confusion 16 matrix, which contrasts the instances of the predicted classes (alive or death) against the 17 actually observed classes. The misclassification--rates reported here are based on the so--18 called out--of--bag errors 25 , which are derived by iteratively testing the models' performances 19 against subsets of data left out during the fitting processes and thus provide a measure of 20 how well the models would fare against unknown data. data are summarized in Supplementary Table 1 . Each isolate was whole--genome sequenced, 7
and quantitatively phenotyped with respect to cytolytic activity (the ability to lyse a 8 monocyte cell line, THP--1) and biofilm formation, both of which are major virulence 9 determinants implicated in S. aureus disease 1,2 . Cytolytic toxins enable the evasion of 10 cellular aspects of host immunity, release nutrient from host cells and are responsible for 11 much of the purulent tissue damage associated of S. aureus infections 1,2 . Biofilm formation 12 enables S. aureus to colonise foreign material and medical devices, protects the bacteria 13 from many aspects of host immunity and renders some antibiotics less effective 1,2 . Despite 14 the close genetic and geographic relationship between these isolates, toxicity and biofilm 15 formation varied widely across the isolates; no association was found between methicillin 16 susceptibility and either virulence phenotype ( fig. 1 ). 17
18
We performed a genome--wide association study (GWAS) to identify loci that were 19 associated with the toxicity of the isolates and their ability to form biofilm, where 20 associations were tested at an uncorrected (P<0.05) and a Bonferroni corrected (P<4.6x10 --5 ) 21 significance threshold ( fig. 2a ). For toxicity, no loci reached significance when using the 22
Bonferroni correction for multiple comparisons, although mutations in the Agr toxicity--23 regulating locus and a putative membrane protein (SAEMRSA15_10750) were marginally 24 associated (0.05 > P > 4.6x10 --5 ). For biofilm, only one locus reached statistical significance, 1 pbp2, a penicillin binding protein. This gene is believed to be essential to the bacteria, as no 2 transposon mutants were available to functionally verify its effect on biofilm. However, 3 members of this family of proteins have been shown previously to affect biofilm 4 formation 26 . A further 37 loci showed marginally significant associations with biofilm 5
( Supplementary  Table  2 ), of which we chose a subset of 12 for functional validation using 6 transposon mutants 27 (Fig.  2b) . Out of these, transposon mutagenesis of six loci showed a 7 significant effect on biofilm formation compared to the wild type: a putative helicase 8 (SAEMRSA15_23880, Tn mutant NE513), the quinolone efflux protein NorA 9 (SAEMRSA15_16820, Tn mutant NE1034), a putative thiamine pyrophosphate 10 enzyme/indole--3--pyruvate decarboxylase (SAEMRSA15_01530, Tn mutant NE1149), and a 11 putative peptidase (SAEMRSA15_04760, Tn mutant NE1455), a putative inosine--uridine 12 preferring nucleoside hydrolase (SAEMRSA15_02020, Tn mutant NE1637, and a hypothetical 13 protein (SAEMRSA15_11850, Tn mutant NE318) ( fig. 2b) . 14
15
Having access to the genetic and phenotypic data for each isolate as well as clinical data 16
( Supplementary Table 1 ) for 92 of the 135 patients, we sought to determine the factors 17 most predictive of severe infection outcome, namely host mortality at day 30. Due to the 18 high dimensionality and high number of possible interactions between the various host and 19 bacterial factors we employed a random forests machine learning approach 24,25 . We 20 compared four scenarios, where the model was fitted against (i) the bacterial genotype data 21 only, (ii) the bacterial phenotype data only, (iii) the clinical data only, and (iv) the entire 22 dataset. Where genotype data were incorporated we first performed a feature selection 23 process, in which the model was fitted against the entire dataset, and a smaller subset of 24 variables selected for further analysis based on their predictive importance, i.e. their 1 contribution to the model's performance in distinguishing between the two classes. This 2 reduced the total number of variables used for fitting down to just 20 (from over 2000 3 initially). factors, suggesting that these may interact in determining infection outcome. In this case, 9 the model yielded a remarkable individual patient--level predictive accuracy of nearly 80% 10 (based on out--of--bag error rates (which is a measure of prediction error)). This is shown by 11 the illustrated confusion matrix in fig. 3b , where the dark--blue diagonal sectors represent 12 the true positive and true negative rates and the light--blue off--diagonal entries represent 13 the false positive and false negative rates.
Random forest can also be used to rank factors based on their relative importance to the 16 predictive power of the model. As illustrated in fig. 3c toxicity and biofilm were the most 17 important features, with patient age and co--morbidities (CCI--class) also playing important 18 roles. Our model also identified a number of other bacterial genetic loci as contributing to 19 disease outcome (listed in Supplementary Tables 3) . Of particular note is the capA gene 20 (indicated as allele_142543 in fig.  3c ), which encodes a capsule biosynthesis enzyme. While 21 the role of capsule in protecting bacteria against several aspects of the host immune system 22 during experimental infections has been established 28,29 , several clinically important clones 23 have evolved to be capsule--negative, due to polymorphisms in the capsule biosynthesis 24 genes 30 . The protective activity of capsule is therefore not critical to the ability of S. aureus 1 to cause disease in humans. Although we have not functionally verified the effect of the 2 polymorphism found here on capsule expression, it suggests that this bacterial phenotype 3 can also vary within a clone and potentially affect infection outcome. 4 5 Based on the ranked importance scores of the different factors used in this model ( fig.  3c ), 6 both toxicity and biofilm formation are highly influential in determining SAB--associated 7 mortality, the former positively and the latter negatively. To further analyse these and 8
illustrate their influence alongside the other important factors we used the random forest 9 approach again to derive two--way partial--dependence plots. As shown in figure 4, the 10 combination of age with high levels of toxicity and/or low levels of biofilm was associated 11 with a significant increase in the risk of patient death. Equally, the comorbidity index 12 (CCI) 18, 19 with any combination of old age, high toxicity, and low levels of biofilm formation 13 considerably increased the probability of severe infection outcomes.

Discussion
16
In this study we demonstrate how combining genotypic, phenotypic and clinical metadata 17 within a mathematical framework can be used to accurately predict the mortality of 18 individual patients following SAB. This work also highlighting the critical role that specific 19 bacterial phenotypes play in affecting the outcome from SAB, providing clarity to an 20 apparent contradiction between experimental animal and human studies. Animal models 21
have demonstrated a clear role for toxins in the severity and disease outcome from SAB 7,8 , 22 however work by us and several other groups have found a negative correlation between 23 toxicity and invasive diseases such as SAB in humans 9--12 . Here our data appears to conflict 24 with our previous work and support the findings of the animal--based studies, which we 1 believe can be reconciled by proposing a sequential pathway of events that distinguishes 2 between the establishment of SAB (i.e. gaining access to the bloodstream) and the 3 subsequent processes associated with a fatal outcome once SAB has become established. 4
Toxin production appears to play disparate roles in these two stages of the disease, being 5 selected against for the initial process of gaining access to the blood stream, but once in the 6 bloodstream it is a major factor leading to host mortality, likely due to the damage and 7 inflammation it causes there. A likely explanation for why animal models of SAB have only 8 confirmed the latter process (disease severity) is that the natural infectious process of 9 gaining access to the bloodstream is bypassed by injecting high doses (typically 10 7 --10 8 10 colony forming units) directly into the animal's bloodstream.
12
From the host perspective, the importance of patient age and co--morbidities in contributing 13 to mortality is consistent with previous findings. However, our modeling approach also 14 demonstrates that these host features can critically interact with bacterial factors and, 15 importantly, allow a prediction of patient outcome with a high degree of accuracy. It is likely 16 that other factors not considered here may influence a patient's risk of death following SAB. 17
Apart from patient care, host genotype and other bacterial phenotypes could have a 18 significant effect on infection outcome. A larger more detailed dataset may enable us to 19 fully identify these factors and unravel their interactions to predict mortality with even 20 higher accuracy. However, given the known epidemiology (with older patients with co--21 morbidities being the most susceptible) and the complexity of this type of disease, it is 22
unlikely that we will achieve 100% predictability, demonstrating the significance of the near 23 80% accuracy reported here. 24 1 With the growing global problem of antimicrobial resistance, alternative intervention and 2 control strategies are needed. These include the development of vaccines and identification 3 of drugs that attenuate the virulence of pathogens. However, without a full understanding 4 of how the bacterial targets for these strategies are involved in causing disease in humans, 5 there is a significant risk of investing in and pursuing unsuccessful lines of therapeutic 6 development. Our findings here, for example, suggest that cytolytic toxins, components of 7 biofilm and possibly capsule are unlikely to be good targets, as they play disparate roles in 8 different stages of disease and their expression is highly variable, even within closely related 9 bacterial clones. Of greater importance, however, it that this work has the potential to make 10 a significant contribution to infectious disease diagnosis and management. With the move 11 towards the introduction of microbial genome sequencing into routine diagnostic settings, 12
the ability to use such information to inform clinicians on the likely outcome of an infection 13 for individual patients would allow them to tailor treatment to that individual, an important 14 step towards the implementation of personalised medicine approaches to infectious disease 15 management. toxicity when Bonferroni was used to correct for multiple comparisons (indicated by the 8 green vertical dotted line). For biofilm, one locus, the pbp2 gene, was significantly associated 9 using the the Bonferroni threshold, and a further 36 using the uncorrected threshold. (b) 10
Twelve of the putative biofilm--affecting loci (associated by GWAS) were functionally 11 validated using transposon insertion, of which six showed a significant effect compared to 12 the wild--type (JE2) (Welch's two--sided t--test, with *: P<2E--2, **: P<2E--4, ***: P<2E--6). 13
Results are based on four biological replicates per strain that were repeated three times 14 each. 15 
